Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Gress

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Oncology (Williston Park, N.Y.)|August 1, 1990
Purged autologous bone marrow transplantation in the treatment of acute leukemiaR E Gress
Cellular Immunology|May 3, 2001
Veto activity of activated bone marrow does not require perforin and Fas ligandP Chrobak, R E Gress
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1992
Cyclosporine A and peripheral tolerance. Inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytesK Hiruma, R E Gress
Transplantation|February 1, 1990
Graft rejection by cytolytic T cells. Specificity of the effector mechanism in the rejection of allogeneic marrowH Nakamura, R E Gress
Transplantation|May 1, 1990
Interleukin 2 enhancement of veto suppressor cell function in T-cell-depleted bone marrow in vitro and in vivoH Nakamura, R E Gress
Immunological Reviews|June 1, 1997
Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapyC L Mackall, R E Gress
Leukemia & Lymphoma|June 1, 2000
Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphomaD H Fowler, R E Gress
Vox Sanguinis|August 15, 1998
CD8+ T cells of Tc2 phenotype mediate a GVL effect and prevent marrow rejectionD H Fowler, R E Gress
Blood|August 1, 1980
The familial occurrence of polycythemia vera: report of a father and son, with consideration of the possible etiologic role of exposure to organic solvents, including tetrachloroethyleneW D Ratnoff, R E Gress
Immunological Reviews|February 26, 1998
Thymic aging and T-cell regenerationC L Mackall, R E Gress
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Oncology (Williston Park, N.Y.)|August 1, 1990
Purged autologous bone marrow transplantation in the treatment of acute leukemiaR E Gress
Cellular Immunology|May 3, 2001
Veto activity of activated bone marrow does not require perforin and Fas ligandP Chrobak, R E Gress
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1992
Cyclosporine A and peripheral tolerance. Inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytesK Hiruma, R E Gress
Transplantation|February 1, 1990
Graft rejection by cytolytic T cells. Specificity of the effector mechanism in the rejection of allogeneic marrowH Nakamura, R E Gress
Transplantation|May 1, 1990
Interleukin 2 enhancement of veto suppressor cell function in T-cell-depleted bone marrow in vitro and in vivoH Nakamura, R E Gress
Immunological Reviews|June 1, 1997
Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapyC L Mackall, R E Gress
Leukemia & Lymphoma|June 1, 2000
Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphomaD H Fowler, R E Gress
Vox Sanguinis|August 15, 1998
CD8+ T cells of Tc2 phenotype mediate a GVL effect and prevent marrow rejectionD H Fowler, R E Gress
Blood|August 1, 1980
The familial occurrence of polycythemia vera: report of a father and son, with consideration of the possible etiologic role of exposure to organic solvents, including tetrachloroethyleneW D Ratnoff, R E Gress
Immunological Reviews|February 26, 1998
Thymic aging and T-cell regenerationC L Mackall, R E Gress
Pageof 11